Tackling liver injury

This image shows liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left. Credit: Marshall et al., 2014

A new drug spurs liver regeneration after surgery, according to a paper published in The Journal of Experimental Medicine.

Liver cancer often results in a loss of blood flow and thus oxygen and nutrients to the , resulting in deteriorating . Although the diseased part of the liver can often be surgically removed, the sudden restoration of blood flow to the remaining liver tissue can trigger inflammation—a process known as ischemia reperfusion injury (IRI). IRI results in part from the deposition of immune proteins called complement on the surface of , causing them to die and thus impairing liver regeneration.

Complement inhibitors effectively dampen IRI, but the benefits of this approach come at a cost, as certain complement proteins are also required for liver tissue to regrow. A group of scientists at the Medical University of South Carolina now show that a novel complement inhibitor reduces complement-mediated liver cell death and actually stimulates post-surgery liver regrowth in mice. The novel inhibitor limited the deposition of complement proteins and promoted the division of new liver cells. Even after removal of as much as 90% of the liver, treatment increased survival from 0% in untreated animals to an impressive 70%.

The selectivity of this novel complement inhibitor, and its unexpected ability to promote , suggests that it might represent a new treatment strategy for a variety of liver injuries in humans.

More information: Marshall, K.M., et al. 2014. J. Exp. Med. DOI: 10.1084/jem.20131902

add to favorites email to friend print save as pdf

Related Stories

Gene mutation may lead to treatment for liver cancer

Jul 08, 2014

Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature.

Recommended for you

Team untangles the biological effects of blue light

5 hours ago

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the ...

Mouse model provides new insight in to preeclampsia

5 hours ago

Worldwide, preeclampsia is a leading cause of maternal deaths and preterm births. This serious pregnancy complication results in extremely high blood pressure and organ damage. The onset of preeclampsia is associated with ...

Scientists unravel the mystery of a rare sweating disorder

5 hours ago

An international research team discovered that mutation of a single gene blocks sweat production, a dangerous condition due to an increased risk of hyperthermia, also known as heatstroke. The gene, ITPR2, controls a basic ...

User comments